Integral Biosciences PVT. Ltd.
Records under this name other than patents Integral Biosciences PVT. Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Integral Biosciences PVT. Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,780,821 | Inhibitors of fibroblast activation protein Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,829,485 | ATF6 inhibitors and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,325,702 | ATF6 inhibitors and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,398,121 | Anti-Cancer Nuclear Hormone Receptor-Targeting Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 11,192,900 | Substituted 1,6-Dihydropyridinones and 1,2-Dihydroisoquinolinones as Bet Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,504,364 | Inhibitors of fibroblast activation protein Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,826,430 | Anti-Cancer Nuclear Hormone Receptor-Targeting Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 11,584,756 | Heterocyclic Compounds as Bet Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,332,473 | SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS WEE1 INHIBITORS Formerly held Lapsed on the fee record Ended May 17, 2026 · High confidence | Lapsed on the fee record | Ended May 17, 2026 | High confidence |
| US 11,318,133 | Modulators of Integrated Stress Response Pathway Formerly held Lapsed on the fee record Ended May 3, 2026 · High confidence | Lapsed on the fee record | Ended May 3, 2026 | High confidence |